Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in finnish women: Effect of hormone replacement therapy

Journal of Bone and Mineral Research

Volumn 15, Issue 2, 2000, Pages 315-321

  Salmén, Timo ^a   Heikkinen, Anna Mari ^b   Mahonen, Anitta ^a   Kröger, Heikki ^b   Komulainen, Marja ^b   Saarikoski, Seppo ^b   Honkanen, Risto ^a   Mäenpää, Pekka H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bone; Estrogen; Menopause; Mineral; Receptor

Indexed keywords

CALCIUM LACTATE; COLECALCIFEROL; CYPROTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; D CALSOR; ESTRADIOL VALERATE; ESTROGEN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FINLAND; GENOTYPE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK;

EID: 0033975956     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.2.315     Document Type: Article

References (34)

1. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287.
2. Kröger H, Mahonen A, Ryhänen S, Turunen A-M, Alhava E, Mäenpää P 1995 Vitamin D receptor genotypes and bone mineral density. Lancet 345:1238.
3. Cooper GS, Umbach DM 1996 Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11:1841-1849.
4. Korach KS 1994 Insights from the study of animals lacking functional estrogen receptor. Science 266:1524-1527.
5. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 331:1056-1061.
6. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S 1987 Genetic determinants of bone mass in adults: A twin study. J Clin Invest 80:706-710.
7. Howard MH, Nguyen TV, Harris M, Kelly PJ, Eisman JA 1998 Genetic and environmental contributions to the association between quantitative ultrasound and bone mineral density measurements: A twin study. J Bone Miner Res 13:1318-1327.
8. Guéguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G 1995 Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10:2017-2022.
9. Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H 1995 Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378-383.
10. Kobayashi S, Inoue S, Hosoi M, Ouchi Y, Shiraki M, Orimo H 1995 Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306-311.
11. Han KO, Moon IG, Choi JT, Kim SW, Yoon HK, Min HK, Han IK 1997 Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 82:991-995.
12. Mahonen A, Turunen A-M, Kröger H, Mäenpää P 1997 Estrogen receptor gene polymorphism is associated with bone mineral density in perimenopausal Finnish women. J Bone Miner Res 12 (Suppl 1):T614.
13. Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, Ouchi Y 1997 Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre-and postmenopausal women. Bone 21:379-383.
14. Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S, Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML 1998 Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939-944.
15. Willing M, Sowers M, Aron D, Clark MK, Bums T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M 1998 Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695-705.
16. Deng H-W, Li J, Li J-L, Johnson M, Gong G, Davis KM, Recker RR 1998 Change of bone mass in postmenopausal Caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet 103:576-585.
17. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC 1976 Long-term prevention of postmenopausal osteoporosis by oestrogen: Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1:1038-1041.
18. Riggs BL, Melton LJ III 1986 Involutional osteoporosis. N Engl J Med 14:1676-1686.
19. 3 in early postmenopausal women: A population-based 5-year randomized trial. J Clin Endocrinol Metab 84:546-552.
20. Christiansen C, Riis BJ, Rodbro P 1987 Prediction of rapid bone loss in postmenopausal women. Lancet 1:1105-1108.
21. Hansen MA, Overgaard K, Riis BJ, Christiansen C 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. Brit Med J 303:961-964.
22. Hassager C, Jensen SB, Christiansen C 1994 Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: Do they exist? Osteoporos Int 4:36-41.
23. Tuppurainen M, Honkanen R, Kröger H, Saarikoski S, Alhava E 1993 Osteoporosis risk factors, gynecological history and fractures in perimenopausal women - the results of the baseline postal enquiry of the Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas 17:89-100.
24. Komulainen M, Kröger H, Tuppurainen MT, Heikkinen A-M, Alhava E, Honkanen R, Saarikoski S 1998 HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial. Maturitas 31:45-54.
25. Komulainen MH, Tuppurainen MT, Kröger H, Heikkinen A-M, Puntila E, Alhava E, Honkanen R, Saarikoski S 1997 Vitamin D and HRT: No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5 year randomized, placebo-controlled study. Osteoporosis Int 7:126-132.
26. Heikkinen A-M, Parviainen M, Niskanen L, Komulainen M, Tuppurainen M, Kröger H, Saarikoksi S 1997 Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3 - A prospective, controlled, randomized study. J Clin Endocrinol Metab 82:2476-2482.
27. Castagnoli A, Mastri I, Bernardi F, Del Senno L 1987 PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15:866.
28. Mosselman S, Polman J, Dijkema R 1996 ER-β: Identification and characterisation of a novel human estrogen receptor. FEBS Lett 392:49-53.
29. Benz DJ, Haussler MR, Komm BS 1991 Estrogen binding and estrogenic responses in normal human osteoblast-like cells. J Bone Miner Res 6:531-541.
30. Kusec V, Virdi AS, Prince R, Triffitt JT 1998 Localization of estrogen receptor-α in human and rabbit skeletal tissues. J Clin Endocrinol Metab 83:2421-2428.
31. Carling T, Rastad J, Akerstrom G, Westin G 1998 Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J Clin Endocrinol Metab 83:2255-2259.
32. Heikkinen A, Parviainen MT, Tuppurainen MT, Niskanen L, Komulainen MH, Saarikoski S 1998 Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Calcif Tissue Int 62:26-30.
33. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ 1992 Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 327:1637-1642.
34. Ooms ME, Roos JC, Bezemer PD, van der Vijgh WJ, Bouter LM, Lips P 1995 Prevention of bone loss by vitamin D supplementation in elderly women: A randomized double-blind trial. J Clin Endocrinol Metab 80:1052-1058.